Gefurulimab Shows Significant Improvement in Daily Function for gMG Patients in Phase III PREVAIL Trial Read more
ENHERTU Plus Pertuzumab Granted U.S. Breakthrough Therapy Status for HER2+ Metastatic Breast Cancer Read more